Accessibility
Animation
Accessibility

The value of the norbuprenorphine/buprenorphine (N/B) ratio in Labcorp’s medication-assisted treatment (MAT) urine drug testing

26 November 2024

The N/B ratio benefits include:

  • Improved buprenorphine compliance
  • Detection of buprenorphine “pill-dipping”
  • Reduction of buprenorphine misuse and potential diversion

Download this new MAT white paper to learn more about our drug testing paradigm and how it helps optimize appropriate care.
 

Learn more about all Labcorp's Clinical Drug Testing